Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Valerius

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Der Internist|July 14, 2001
[Bispecific antibodies in hematology and oncology]R Repp, T Valerius, R Bargou
Methods in Molecular Biology (Clifton, N.J.)|January 5, 2002
Using progenitor cells and gene chips to define genetic pathwaysS S Potter, M T Valerius, E W Brunskill
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1990
Effects of IFN on human eosinophils in comparison with other cytokines. A novel class of eosinophil activators with delayed onset of actionT Valerius, R Repp, J R Kalden, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 29, 1998
CA 125 elevations in patients with malignant lymphomasT Fehm, E Beck, T Valerius, et al.
Cancer Immunology, Immunotherapy : CII|November 4, 2023
Organ-on-a-chip models for development of cancer immunotherapiesM Chernyavska, M Masoudnia, T Valerius, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 24, 1997
Renal dysfunction in a human immunodeficiency virus-infected patient who was treated with indinavirM Grunke, T Valerius, B Manger, et al.
European Journal of Cancer (Oxford, England : 1990)|January 25, 2000
GM-CSF as adjuvant for immunotherapy with bispecific antibodiesD Elsässer, H Stadick, J G van de Winkel, et al.
Journal of Immunological Methods|May 12, 2009
Serum-free production and purification of chimeric IgA antibodiesT Beyer, S Lohse, S Berger, et al.
The EMBO Journal|February 15, 1996
Gsh-1, an orphan Hox gene, is required for normal pituitary developmentH Li, P S Zeitler, M T Valerius, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 1998
Activated neutrophils as effector cells for bispecific antibodiesT Valerius, D Würflein, B Stockmeyer, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Der Internist|July 14, 2001
[Bispecific antibodies in hematology and oncology]R Repp, T Valerius, R Bargou
Methods in Molecular Biology (Clifton, N.J.)|January 5, 2002
Using progenitor cells and gene chips to define genetic pathwaysS S Potter, M T Valerius, E W Brunskill
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1990
Effects of IFN on human eosinophils in comparison with other cytokines. A novel class of eosinophil activators with delayed onset of actionT Valerius, R Repp, J R Kalden, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 29, 1998
CA 125 elevations in patients with malignant lymphomasT Fehm, E Beck, T Valerius, et al.
Cancer Immunology, Immunotherapy : CII|November 4, 2023
Organ-on-a-chip models for development of cancer immunotherapiesM Chernyavska, M Masoudnia, T Valerius, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 24, 1997
Renal dysfunction in a human immunodeficiency virus-infected patient who was treated with indinavirM Grunke, T Valerius, B Manger, et al.
European Journal of Cancer (Oxford, England : 1990)|January 25, 2000
GM-CSF as adjuvant for immunotherapy with bispecific antibodiesD Elsässer, H Stadick, J G van de Winkel, et al.
Journal of Immunological Methods|May 12, 2009
Serum-free production and purification of chimeric IgA antibodiesT Beyer, S Lohse, S Berger, et al.
The EMBO Journal|February 15, 1996
Gsh-1, an orphan Hox gene, is required for normal pituitary developmentH Li, P S Zeitler, M T Valerius, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 1998
Activated neutrophils as effector cells for bispecific antibodiesT Valerius, D Würflein, B Stockmeyer, et al.
Pageof 7